%0 Journal Article
%T Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
%A Chien-Hsu Lai
%A Yen-Yu Chen
%A Yi-Chun Yeh
%J Archive of "Therapeutic Advances in Drug Safety".
%D 2019
%R 10.1177/2042098619854007
%X Metoclopramide is used to relieve gastrointestinal symptoms, however, it could cause adverse reactions of motor disorders. The aim of this study was to investigate whether metoclopramide treatment has a duration¨Cresponse or dose¨Cresponse effect and to estimate the risk of developing Parkinsonism following different and specific durations of treatment
%K metoclopramide
%K Parkinsonism
%K type 2 diabetes
%K Taiwan
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587390/